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Abstract
The common variants in the fat mass- and obesity-associated (FTO) gene have been previously found to be associated with obesity 
in various adult populations. The objective of the present study was to investigate whether the single nucleotide polymorphisms 
(SNPs) and linkage disequilibrium (LD) blocks in various regions of the FTO gene are associated with predisposition to obesity 
in Malaysian Malays. Thirty-one FTO SNPs were genotyped in 587 (158 obese and 429 non-obese) Malaysian Malay subjects. 
Obesity traits and lipid profiles were measured and single-marker association testing, LD testing, and haplotype association 
analysis were performed. LD analysis of the FTO SNPs revealed the presence of 57 regions with complete LD (D’ = 1.0). In 
addition, we detected the association of rs17817288 with low-density lipoprotein cholesterol. The FTO gene may therefore be 
involved in lipid metabolism in Malaysian Malays. Two haplotype blocks were present in this region of the FTO gene, but no 
particular haplotype was found to be significantly associated with an increased risk of obesity in Malaysian Malays.
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Introduction 
The World Health Organization (WHO) defines overweight as a body mass index (BMI) of >25 kg/m2 and obesity as a 
BMI of >30 kg/m2. The WHO has reported that, globally, overweight and obesity represent the fifth leading risk for death; 
furthermore, 44% of the diabetes burden, 23% of the ischemic heart disease burden, and between 7 and 41% of certain 
cancer burdens are related to overweight and obesity. Obesity is a complex disorder, with genetic and non-genetic fac-
tors playing crucial roles in an individual’s predisposition to it. Many recent studies, including genome-wide association 
studies (GWAS), have reported that single nucleotide polymorphisms (SNPs) are associated with obesity-related traits 
in various populations (1-5).
FTO gene variants have been widely studied for their association with obesity. Frayling et al. (1) first discovered in a 
GWAS that the rs9939609 variant of FTO, with clusters of SNPs in the first intron, was strongly associated with BMI in 
the UK population. Following this finding, an association between FTO SNPs and obesity traits was detected in people 
of European ancestry (2), Sardinians (6), and African Americans (7), as well as in a Belgian cohort (8), East Asian popu-
lation (9), Japanese population (10,11), a Sorbian population in Germany (12), a Chinese population in Beijing (13), 
in an Indian population (14), and many other populations. Compared with other FTO variants, rs9939609 showed the 
strongest effect on BMI in these studies. 
FTO is expressed in the hypothalamus, a region that is crucial for the control of appetitive behavior (15,16). Animal 
studies have shown that FTO has an effect on energy homeostasis (17), but the true physiological role of FTO is yet 










to be explored (18). Although initial reports on FTO stated that the functions and pathways linked to the FTO gene are 
largely unknown (1), structural analysis of FTO has revealed that it belongs to members of the non-heme 2-oxoglutarate-
dependent oxygenase superfamily, which are involved in post-translational modification, DNA repair, and fatty acid 
metabolism (19,20). Recent studies have suggested that FTO may play an important role in adipogenesis, lipogenesis, 
and mitochondrial function in skeletal muscle (21,22).
In the current study, our objective was to examine the effects of FTO SNPs on obesity-related traits and to study the 
linkage disequilibrium (LD) pattern and haplotype block in the Malaysian Malays. To accomplish this, we genotyped 31 
SNPs on the FTO gene selected from previous studies and GWAS.
Subjects and Methods
Subjects
The participants were 587 subjects from the Wellness Program of a public university in Kuala Lumpur, an annual 
voluntary health screening program for the staff, as well as from a community of the Bera district of Pahang, a state on 
the east coast of Peninsular Malaysia. All subjects reported that they belonged to the Malay ethnic group for at least three 
generations. In accordance with the WHO cutoffs for obesity, subjects with a BMI of 30 kg/m2 were categorized as obese 
and those with a BMI below 30 kg/m2 as non-obese. The Medical Ethics Committee (MEC Ref. No. 672.23) of the uni-
versity Medical Center approved the study protocol and written informed consent was obtained from all participants.
Clinical measurements
Anthropometric measurements such as height, body weight, BMI, waist circumference, hip circumference, waist-to-
hip ratio, systolic blood pressure, and diastolic blood pressure were recorded. After an overnight fast, 10 to 15 mL blood 
was collected from each subject for routine biochemical measurements. Total cholesterol, total triglyceride, high-density 
lipoprotein cholesterol, serum low-density lipoprotein cholesterol (LDL-C), and triglyceride levels were measured using 
standard clinical laboratory techniques.
DNA isolation from human buccal swabs
Buccal swabs were collected and genomic DNA was obtained by using the i-genomic CTB DNA extraction kit (iNtRON 
Biotechnology, Korea). This extraction procedure consists of six main steps: prelysis, lysis, precipitation, DNA binding, 
washing, and elution with buffers, proteinase K, and RNase A.
DNA measurement
The concentration and purity of DNA was measured using a Nanodrop spectrophotometer to determine absorbance 
at wavelengths of 260 and 280 nm and by agarose gel electrophoresis.
Sequenom MassARRAY® iPLEX Platform (MALDI-TOF)
Genotyping of 31 SNPs of the FTO gene was performed with the Sequenom MassARRAY platform (Sequenom, USA). 
The variants were selected from information provided by previous GWAS and association studies in various populations.
Statistical analysis
Hardy-Weinberg equilibrium (HWE) was determined in both cases and controls (23) and genotype and allelic frequen-
cies were also determined in cases and controls. Prior to statistical analysis, BMI and triglyceride data were normalized 
by natural log transformation. The general linear method was used to adjust for age and gender when assessing the 
effects of SNPs on obesity parameters and lipid levels. The results of association analysis for the SNPs and obesity 
parameters indicated that the additive model best fitted the data. Data are reported as means ± SD. Bonferroni’s adjust-
ment was performed to correct for multiple tests on multiple markers (α = 0.05/30). Statistical analysis was performed 
using the SPSS version 16 software. 
LD block construction and haplotype analysis were performed with the Haploview software (version 4.2) to measure 
the LD coefficient (D’). A permutation test with 5000 replications was used to obtain empirical levels of significance. Ad-
justment for multiple testing was performed by obtaining P values from the permutation test with the Haploview software. 
The power of the study, calculated using the Quanto version 1.2.4 software, was 87%.
Results
Table 1 shows the characteristics of the 587 subjects who participated in the study. The allele frequencies of 30 SNPs 










in the FTO gene are summarized in Table 2. The FTO rs1861869 SNP deviated from Hardy-Weinberg equilibrium (HWE 
case: control = 0.863:0.025) and was therefore not included in the analysis. After Bonferroni’s correction and a permuta-
tion test with 5000 replications for the 30 SNPs, there was no significant difference in allelic frequency for any of the FTO 
SNPs between the obese and non-obese groups. Table 3 shows the genotype frequencies of all FTO SNPs. There was 
no significant difference in genotype frequency for any of the FTO SNPs between the obese and non-obese groups.
The results of testing the single-marker association of 30 FTO SNPs with obesity traits are summarized in Figure 1. 
After Bonferroni’s adjustment was performed for multiple corrections, α was 0.016 (-log P = 2.70). The SNP rs17817288 
was significantly associated with LDL-C (P = 0.001) in Malaysian Malays after adjustment for age and gender. None of 
other SNPs presented a significant association with obesity parameters.
Figure 2 shows the LD pattern of the FTO gene. D prime value (D’) of 100% indicates the complete LD. D’ values of 
100% are not shown (the box is empty). The boxes in bright red are with D’ values of 100%. The boxes with values of D’ 
<100% are in shades of pink or red. When we examined the LD of the FTO region, we found two haplotype blocks of 1 
and 44 kb. The strongest LD was seen in the second block, which showed 48 regions with complete LD and 69 regions 
with high LD (D’ = 80-99%). 
There are 11 haplotypes in the region of the FTO gene. Table 4 shows the first and second blocks of the FTO haplo-
types. The GA, AA, and AG haplotypes in block 1 showed frequencies of 36, 33, and 32%, respectively. In block 2, the 
TTCCGCATCGGTGCGC, CACCGTAGAATAGTGA, CACGGTAGAATAGTGC, TTTCACATCGGTGTAC, TTTCACATCGG 
TATGC, and TTCCGCGTCGGTGTGC, haplotypes had frequencies of 32, 14, 14, 13, 12, and 5%, respectively. The TTCC 
ATGTCGGTGTGC and CACCGTAGAATAGTGC haplotypes had lower frequencies (<5%). There were no significant 
differences in haplotype frequencies between obese and non-obese subjects. After permutation test correction with 5000 
permutations, none of the haplotypes was associated with obesity. 
Discussion
There were no significant differences in allelic or genotype frequencies of the 30 FTO SNPs between the obese and 
non-obese groups in the Malaysian Malay population. Recent studies have pointed out that the SNPs in the FTO gene 
contribute to obesity and obesity-related traits in various populations around the globe (1,3,24-27). Single-marker analysis 
revealed that rs17817288 was significantly associated with LDL-C levels (P = 0.001) in Malaysian Malays. A recent study 
(22) showed that, as a transcriptional coactivator, FTO might play an important role in the transcriptional regulation of 
adipogenesis, and suggested that FTO might be involved in the regulation of fat development and maintenance. There-
fore, we speculated that the FTO rs17817288 SNP may have an effect on adipogenesis in Malaysian Malays, which is 
consistent with findings by Wu et al. (22) concerning the functional effects of the FTO gene. The FTO rs9939609 SNP 
was chosen as representative of FTO SNPs in the present study because this locus was highlighted in many studies as 
having the strongest effect on obesity; it was also the key signal identified in the GWAS (1). A meta-analysis reported 
that 21 of 29 studies have shown a significant association between obesity and rs9939609 (5). However, this SNP had 
no effect on obesity in the Malaysian Malay population. 
A meta-analysis reported that the minor allele frequency (MAF) for rs9939609 varies across the global population. 
The MAF of the FTO rs9939609 polymorphism was lower (0.31) in the Malaysian Malay population compared to the 
previously reported range of 0.38 to 0.46 in European populations (1,8,28). For example, the MAF was 0.31 to 0.37 in 
Hispanics, 0.34 to 0.44 in Caucasians, 0.17 in South Americans, 0.36 in Africans, 0.11 to 0.20 in Asians, 0.25 in Sin-
gaporean Malays, 0.13 in Singaporean Chinese, and 0.42 in Singaporean Indians (5,29,30). In addition, the MAF for 
rs1421085, rs1558902, rs17817449, rs3751812, rs9939609, and rs8050136 was similar across these six SNPs. The 
MAF for the SNPs is 0.31. 
We investigated the LD structure of the FTO SNPs in Malaysian Malays. Linkage analysis showed 57 regions with 
complete LD in the FTO gene. Our results showed that 15 of the 30 FTO SNPs (50%) are in high LD (D ≥ 0.88) with 
rs9939609. This indicates that the FTO SNPs in the first intron of the FTO gene are high in LD in Malaysian Malays. In 
our samples, three SNPs, rs9935401, rs16945088, and rs10852521 (D’ = 1.0), were in complete LD with rs9939609. 
In the HapMap sample of Utah residents with ancestry from northern and western Europe (CEU), the three SNPs 
rs10852521, rs16945088, and rs9935401 are in complete LD (D’ = 1.0) with rs9939609, as observed in our sample of 
Malaysian Malays. In contrast, in the HapMap sample of Yoruba in Ibadan, Nigeria (YRI), the rs9939609 at rs10852521 
is not in strong LD (D’ = 0.48). Complete LD (D = 1.0) with rs9939609 at rs16945088 and at rs17817449 has been shown 
in HapMap samples of African ancestry in Southwest USA (ASW); Utah residents with northern and western European 
ancestry (CEU); Han Chinese in Beijing, China (CHB); Chinese in Metropolitan Denver, Colorado (CHD); Gujarati Indians 
in Houston, Texas (GIH); Japanese in Tokyo, Japan (JPT); Luhya in Webuye, Kenya (LWK); Mexican ancestry in Los 
Angeles, California (MEX); Tuscans in Italy (TSI), and Yoruba in Ibadan, Nigeria (YRI). A similar LD strength was observed 










in our samples of Malaysian Malays. Interestingly, results from HapMap samples show that rs9939609 is in complete LD 
with rs10852521 with samples from Asia (JPT, CHD, and CHB), which was also replicated in our samples of Malaysian 
Malays. In contrast, the strength of LD of rs9939609 at rs10852521 is reduced in samples of African ancestry such as 
YRI, ASW, LWK, and Maasai in Kinyawa, Kenya (MKK; D > 0.35) (31).
The Singaporean Genome Variation Project analyzed the LD in 98 Singaporean Malays (MAS) with the Affymetric 
Genome-Wide Human SNP Array and the Illumina Human1M single-sample BeadChip genotyping platforms (29). In 
our study, we found that the LD pattern of all regions with complete LD in Malaysian Malays was similar to the MAS 
samples except for rs17218700 and rs7190492. The LD of rs17218700 with rs7190492 was lower in the MAS samples 
(D’ = 0.74) compared with those in our study. By using the Sequenom MassARRAY® iPLEX platform with a much larger 
sample size (N = 587), we found that the LD pattern from our own data for Malaysian Malays is very similar to that of 
the MAS samples. Therefore, we can predict a similar pattern of LD in the FTO gene ancestry of Malays in Southeast 
Asia because of the genetic homogeneity. Further studies will be needed to address this pattern in Malays in other parts 
of Southeast Asia. 
Differences exist in the LD structure of the FTO gene in diverse ethnic populations (5). For example, previous studies 
have shown that the degree of LD in a population with African ancestry is lower than that in European populations (32). 
Recent studies have reported that the genetic variability in the FTO gene that is in high LD are associated with a risk of 
obesity in Spanish (33) and African Americans (27). Our study showed novel patterns of LD in the FTO gene ancestry 
of Malaysian Malays. 
Most FTO haplotypes were found to have frequencies of more than 5% in Malaysian Malays. We identified major 
haplotypes in people of Malaysian Malay ancestry that may also be present in Malays in other parts of Southeast Asia. 
Studies of different populations will be needed, however, to confirm this finding. The haplotypes in block 1 and block 2 
of the FTO gene were not associated with obesity in Malaysian Malays.
Previous studies on the association of the FTO gene with obesity included between 240 and 5380 subjects from popu-
lations across the globe (5). Although the sample investigated in the present study was of moderate size in comparison 
with other studies, this study was sufficiently powered with the population of Malaysian Malays. Since the participants of 
this study are middle-aged and elderly individuals, these findings cannot be generally extrapolated to children and ado-
lescents in Malaysia. This study was conducted in Malaysian Malays, and we cannot generalize these findings to overall 
Malaysian populations such as Chinese, Indians and other ethnic groups in Malaysia. Therefore, large-scale genetic 
association studies on FTO should be carried out in future in other ethnic groups within the Malaysian population. 
To the best of our knowledge, this is the first study on genetic variants in the FTO gene in Malaysian Malays. We 
conclude that the genetic variations in the FTO gene are in high LD in this ethnic group. Two haplotype blocks of FTO 
were identified, neither of which confers an increased risk for obesity in this population. We detected the association 
of rs17817288 with LDL-C, and this SNP may be involved in lipid metabolism in Malaysian Malays. Replication of this 
association in larger samples and in functional molecular studies will further increase the validity of this association and 
the causative relationship between the FTO variant and LDL-C.
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Table 1. Characteristics of the subjects in this study.
Characteristics Non-obese subjects Obese subjects Pooled subjects
Height (m) 1.59 ± 0.09 (N = 429) 1.57 ± 0.09 (N = 158) 1.58 ± 0.09 (N = 587)
Weight (kg) 63.25 ± 10.77 (N = 429) 83.32 ± 11.82 (N = 158) 68.65 ± 14.20 (N = 587)
BMI (kg/m2) 24.92 ± 3.09 (N = 429) 33.83 ± 3.18 (N = 158) 27.32 ± 5.04 (N = 587)
WC (cm) 85.25 ± 10.22 (N = 429) 100.76 ± 8.57 (N = 158) 89.43 ± 11.97 (N = 587)
HC (cm) 98.17 ± 7.31 (N = 429) 113.18 ± 8.04 (N = 158) 102.21 ± 10.04 (N = 587)
WHR 0.87 ± 0.08 (N = 429) 0.89 ± 0.07 (N = 158) 0.87 ± 0.08 (N = 587)
SBP (mmHg) 128.55 ± 17.38 (N = 429) 137.04 ± 18.32 (N = 158) 130.84 ± 18.02 (N = 587)
DBP (mmHg) 80.46 ± 11.38 (N = 428) 87.35 ± 12.28 (N = 158) 82.32 ± 12.02 (N = 586)
TG (mM) 1.42 ± 0.93 (N = 302) 1.56 ± 0.67 (N = 107) 1.46 ± 0.86 (N = 409)
HDL-C (mM) 1.32 ± 0.28 (N = 302) 1.25 ± 0.25 (N = 107) 1.30 ± 0.27 (N = 409)
TC (mM) 5.49 ± 0.91 (N = 302) 5.43 ± 0.98 (N = 107) 5.47 ± 0.93 (N = 409)
LDL-C (mM) 3.53 ± 0.80 (N = 299) 3.46 ± 0.87 (N = 106) 3.51 ± 0.82 (N = 405)
Age (years) 48.16 ± 10.19 (N = 429) 48.66 ± 9.03(N = 158) 48.29 ± 9.89 (N = 573)
Data are reported as means ± SD, with number of patients within parentheses. BMI = body mass 
index; WC = waist circumference; HC = hip circumference; WHR = waist-to-hip ratio; SBP = systolic 
blood pressure; DBP = diastolic blood pressure; TG = triglyceride; HDL-C = high-density lipoprotein 
cholesterol; TC = total cholesterol; LDL-C = low-density lipoprotein cholesterol.

















χ2 (d.f. = 1)  P HWE
(cases/controls)
rs1077128 53791653 0.336 G G:T 0.668, 0.662 0.034 1.000 0.137/0.516
rs11643744 53791798 0.355 G A:G 0.370, 0.350 0.428 1.000 0.785/0.759
rs7186521 53792922 0.32 A A:G 0.684, 0.678 0.029 1.000 0.134/0.892
rs13334933 53795636 0.337 A A:G 0.671, 0.660 0.13 1.000 0.212/0.563
rs16952517 53797057 0.27 A G:A 0.304, 0.258 2.503 0.9198 0.538/0.522
rs6499643 53797518 0.226 T T:C 0.804, 0.763 2.156 0.9694 0.970/0.420
rs4784323 53797565 0.129 G G:A 0.873, 0.869 0.032 1.000 0.297/0.472
rs7206790 53797908 0.296 G C:G 0.297, 0.295 0.007 1.000 0.394/0.944
rs9939973 53800568 0.34 A G:A 0.345, 0.338 0.05 1.000 0.278/0.519
rs1421085 53800954 0.307 C T:C 0.313, 0.304 0.09 1.000 0.210/0.451
rs1558902 53803574 0.307 A T:A 0.313, 0.304 0.09 1.000 0.210/0.451
rs10852521 53804965 0.266 C C:T 0.741, 0.732 0.087 1.000 0.343/0.839
rs16952522 53807498 0.156 G C:G 0.171, 0.150 0.74 1.000 0.718/0.212
rs17817288 53807764 0.298 G G:A 0.709, 0.699 0.101 1.000 0.558/0.856
rs1121980 53809247 0.342 T C:T 0.345, 0.340 0.022 1.000 0.778/0.619
rs16945088 53812524 0.084 A A:G 0.918, 0.915 0.024 1.000 0.996/0.493
rs17817449 53813367 0.307 G T:G 0.316, 0.303 0.196 1.000 0.134/0.890
rs8050136 53816275 0.307 A C:A 0.313, 0.304 0.09 1.000 0.210/0.766
rs9935401 53816838 0.308 A G:A 0.316, 0.305 0.133 1.000 0.134/0.820
rs3751812 53818460 0.307 T G:T 0.313, 0.304 0.09 1.000 0.210/0.766
rs9939609 53820527 0.307 A T:A 0.316, 0.304 0.163 1.000 0.134/0.766
rs7190492 53828752 0.129 A G:A 0.136, 0.126 0.214 1.000 0.165/0.598
rs7204609 53833605 0.338 C T:C 0.348, 0.334 0.191 1.000 0.703/0.278
rs17218700 53844579 0.135 G G:A 0.886, 0.857 1.709 0.986 0.462/0.748
rs11642841 53845487 0.145 C C:A 0.864, 0.852 0.266 1.000 0.476/0.358
rs1861867 53848561 0.126 T C:T 0.130, 0.125 0.053 1.000 0.352/0.303
rs11075994 53850079 0.127 G G:A 0.899, 0.864 2.567 0.913 0.747/0.993
rs1421090 53850170 0.344 C T:C 0.399, 0.324 5.713 0.331 0.217/0.514
rs17818902 53871806 0.245 T T:G 0.756, 0.754 0.006 1.000 0.810/0.613
rs7191513 53990523 0.323 A G:A 0.348, 0.314 1.263 0.997 0.074/0.793
MAF = minor allele frequency; d.f. = degrees of freedom; HWE = Hardy-Weinberg equilibrium. *P value was generated using 5000 
permutated chi-squares.










Table 3. Genotype distribution among obese and non-obese subjects.
Non-obese Obese
rs1077128 GG GT TT GG GT TT
43.12 46.15 10.72 47.47 38.61 13.92
rs10852521 CC TC TT CC TC TT
53.38 39.63 6.99 56.33 35.44 8.23
rs11075994 AA AG GG AA AG GG
1.86 23.54 74.59 1.27 17.72 81.01
rs1121980 CC TC TT CC TC TT
44.06 43.82 12.12 44.94 41.14 13.92
rs11642841 AA CA CC AA CA CC
1.63 26.34 72.03 2.53 22.15 75.32
rs11643744 AA GA GG AA GA GG
41.96 46.15 11.89 39.24 47.47 13.29
rs13334933 AA AG GG AA AG GG
42.89 46.15 10.96 47.47 39.24 13.29
rs1421085 CC CT TT CC CT TT
10.03 40.79 49.18 12.03 38.61 49.37
rs1421090 CC CT TT CC CT TT
11.19 42.42 46.39 18.35 43.04 38.61
rs1558902 AA AT TT AA AT TT
10.02 40.79 49.18 12.03 38.61 49.37
rs16945088 AA AG GG AA AG GG
83.45 16.08 0.47 84.18 15.19 0.63
rs16952517 AA AG GG AA AG GG
7.23 37.06 55.71 10.13 40.51 49.37
rs16952522 CC GC GG CC GC GG
72.96 24.01 3.03 68.35 29.11 2.53
rs17218700 AA AG GG AA AG GG
1.86 24.94 73.19 1.9 18.99 79.11
rs17817288 AA AG GG AA AG GG
8.86 42.42 48.72 9.49 39.24 51.27
rs1861867 GG GT TT GG GT TT
77.16 20.75 2.1 76.58 20.89 2.53
rs3751812 GG GT TT GG GT TT
48.72 41.72 9.56 49.37 38.61 12.03
rs4784323 AA GA GG AA GA GG
2.1 21.91 75.99 2.53 20.25 77.22
rs6499643 CC TC TT CC TC TT
4.9 37.53 57.58 3.8 31.65 64.56
rs7186521 AA GA GG AA GA GG
46.15 43.36 10.49 49.37 37.97 12.66
rs7190492 AA AG GG AA AG GG
1.86 21.45 76.69 3.16 20.89 75.95
rs7191513 AA GA GG AA GA GG
9.55 43.59 46.85 15.19 39.24 45.57
rs7204609 CC TC TT CC TC TT
12.35 42.19 45.45 12.66 44.3 43.04
rs7206790 CC CG GG CC CG GG
49.65 41.72 8.62 50.63 39.24 10.13
rs8050136 AA CA CC AA CA CC
9.56 41.72 48.72 12.03 38.61 49.37
rs9935401 AA GA GG AA GA GG
9.56 41.96 48.48 12.66 37.97 49.37
rs9939609 AA AT TT AA AT TT
9.56 41.72 48.72 12.66 37.97 49.37
rs9939973 AA AG GG AA AG GG
12.12 43.36 44.52 13.92 41.14 44.94
rs17817449 GG GT TT GG GT TT
9.32 41.96 48.72 12.66 37.97 49.37
rs17818902 GG GT TT GG GT TT
5.59 38 56.41 6.33 36.08 57.59
*P value was generated using the chi-square test. There was 
no significance difference in genotype frequency of each of the 
SNP between the obese and non-obese subjects.










Table 4. Haplotype analysis of the FTO gene.
Haplotype Frequency Frequencies 
(cases, controls) 
Block 1
GA 0.355 0.370, 0.350
AA 0.325 0.313, 0.329
AG 0.32 0.316, 0.322
Block 2
TTCCGCATCGGTGCGC 0.324 0.330, 0.324
CACCGTAGAATAGTGA 0.139 0.130, 0.144
CACGGTAGAATAGTGC 0.138 0.152, 0.134
TTTCACATCGGTGTAC 0.131 0.114, 0.138
TTTCACATCGGTATGC 0.123 0.133, 0.121
TTCCGCGTCGGTGTGC 0.053 0.054, 0.053
TTCCATGTCGGTGTGC 0.032 0.029, 0.033
CACCGTAGAATAGTGC 0.022 0.026, 0.021
*P value was generated using 5000 permutated chi-squares. 
There was no significance difference in haplotype frequency of 
each of the haplotypes between the obese and non-obese sub-
jects.










Figure 1. Log10 of the P value for single-marker association of FTO SNPs with obesity traits after adjustment for age and 
gender. For abbreviations, see legend to Table 1.










Figure 2. Linkage disequilibrium pattern of FTO single nucleotide polymorphisms. D prime value (D’) of 100% indicates 
the complete LD. D’ values of 100% are not shown (the box is empty). The boxes in bright red are with D’ values of 100%. 
The boxes with values of D’ <100% are in shades of pink or red. 
